Search results
Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates
Zacks via Yahoo News· 12 hours agoJakafi is a first-in-class JAK1/JAK2 inhibitor. INCY has a collaboration agreement with the Swiss...
What to Do if You Can’t Afford Your Medications
Time via Yahoo News· 5 days agoA one-time-use coupon for Medicare recipients from Novartis, the drug’s manufacturer, reduced the cost to zero. He has also used coupons to help manage...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo News· 6 days agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...